Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Benjamin LandryGeneral Counsel | Health CatalystHCAT | Open-market sale10b5-1 plan | 25/12/05 | 25/12/09 | 27,425 sh | $2.64 | $72,402 | −21.5% |
Julie Larson-GreenDirector | Health CatalystHCAT | Open-market sale | 25/12/04 | 25/12/09 | 47,997 sh | $2.67 | $128,151.99 | −39.5% |
Benjamin LandryGeneral Counsel | Health CatalystHCAT | Open-market sale10b5-1 plan | 25/09/05 | 25/09/09 | 6,175 sh | $3.35 | $20,686.25 | −4.2% |
Benjamin LandryGeneral Counsel | Health CatalystHCAT | Open-market sale10b5-1 plan | 25/06/05 | 25/06/09 | 6,057 sh | $3.94 | $23,864.58 | −3.9% |
Health CatalystHCAT | Open-market sale10b5-1 plan | 25/05/05 | 25/05/07 | 5,209 sh | $4.10 | $21,356.9 | −2.5% | |
Health CatalystHCAT | Open-market sale10b5-1 plan | 25/04/03 | 25/04/07 | 5,209 sh | $4.15 | $21,617.35 | −2.4% | |
Benjamin LandryGeneral Counsel | Health CatalystHCAT | Open-market sale10b5-1 plan | 25/03/06 | 25/03/10 | 13,827 sh | $4.55 | $62,912.85 | −7.9% |
Health CatalystHCAT | Open-market sale10b5-1 plan | 25/03/05 | 25/03/10 | 16,902 sh | $4.52 | $76,397.04 | −7.2% | |
Linda LlewelynChief People Officer | Health CatalystHCAT | Open-market sale10b5-1 plan | 25/02/18 | 25/02/20 | 6,441 sh | $5.43 | $34,974.63 | −7.0% |
Health CatalystHCAT | Open-market sale10b5-1 plan | 25/02/05 | 25/02/06 | 5,209 sh | $5.76 | $30,003.84 | −5.7% | |
Linda LlewelynChief People Officer | Health CatalystHCAT | Open-market sale10b5-1 plan | 25/01/15 | 25/01/17 | 6,442 sh | $5.80 | $37,363.6 | −6.5% |
Benjamin LandryGeneral Counsel | Health CatalystHCAT | Open-market sale10b5-1 plan | 25/01/06 | 25/01/10 | 2,500 sh | $7.52 | $18,800 | −3.3% |
Health CatalystHCAT | Open-market sale10b5-1 plan | 25/01/06 | 25/01/10 | 5,209 sh | $7.51 | $39,119.59 | −5.4% | |
Duncan GallagherDirector | Health CatalystHCAT | Open-market sale10b5-1 plan | 24/12/30 | 25/01/02 | 4,500 sh | $6.93 | $31,185 | −6.0% |
Duncan GallagherDirector | Health CatalystHCAT | Open-market sale10b5-1 plan | 24/12/23 | 24/12/27 | 4,500 sh | $6.98 | $31,410 | −5.7% |
Linda LlewelynChief People Officer | Health CatalystHCAT | Open-market sale10b5-1 plan | 24/12/16 | 24/12/18 | 6,442 sh | $7.88 | $50,762.96 | −6.1% |
Jason AlgerCFO | Health CatalystHCAT | Open-market sale10b5-1 plan | 24/12/06 | 24/12/10 | 19,599 sh | $8.32 | $163,063.68 | −18.4% |
Benjamin LandryGeneral Counsel | Health CatalystHCAT | Open-market sale10b5-1 plan | 24/12/06 | 24/12/10 | 19,268 sh | $8.32 | $160,309.76 | −21.1% |
Health CatalystHCAT | Open-market sale10b5-1 plan | 24/12/04 | 24/12/06 | 22,773 sh | $7.70 | $175,352.1 | −19.1% | |
Kevin Lee FreemanChief Commercial Officer | Health CatalystHCAT | Open-market sale | 24/12/02 | 24/12/03 | 7,500 sh | $8.94 | $67,050 | −3.1% |